PharmaEssentia Corporation (TPE:6446)
494.50
-1.00 (-0.20%)
Dec 19, 2025, 1:35 PM CST
PharmaEssentia Market Cap
PharmaEssentia has a market cap or net worth of 182.89 billion as of December 19, 2025. Its market cap has decreased by -5.59% in one year.
Market Cap
182.89B
Enterprise Value
162.20B
Revenue
13.82B
Ranking
n/a
PE Ratio
38.19
Stock Price
494.50
Market Cap Chart
Since March 11, 2014, PharmaEssentia's market cap has increased from 39.38B to 182.89B, an increase of 364.37%. That is a compound annual growth rate of 13.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 183.26B | -10.49% |
| Dec 31, 2024 | 204.73B | 78.68% |
| Dec 29, 2023 | 114.58B | -20.34% |
| Dec 30, 2022 | 143.84B | 84.26% |
| Dec 30, 2021 | 78.07B | 215.94% |
| Dec 31, 2020 | 24.71B | 2.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 244.27B |
| Heron Neutron Medical | 87.79B |
| Lotus Pharmaceutical | 75.08B |
| Bora Pharmaceuticals Co., LTD. | 62.46B |
| Lin BioScience | 32.88B |
| Lumosa Therapeutics | 31.84B |
| Center Laboratories | 28.07B |
| Oneness Biotech | 27.70B |